TLX2
gene geneOn this page
Also known as EnxNCX
Summary
TLX2 (T cell leukemia homeobox 2, HGNC:5057) is a protein-coding gene on chromosome 2p13.1, encoding T-cell leukemia homeobox protein 2 (O43763). Transcription activator that binds DNA elements with the consensus sequence 5’-CGGTAATTGG-3'.
This gene is a member of an orphan homeobox-containing transcription factor family. Studies of the mouse ortholog have shown that the encoded protein is crucial for the development of the enteric nervous system; in humans, loss-of-function may play a role in tumorigenesis of gastrointestinal stromal tumors.
Source: NCBI Gene 3196 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_016170
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:5057 |
| Approved symbol | TLX2 |
| Name | T cell leukemia homeobox 2 |
| Location | 2p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Enx, NCX |
| Ensembl gene | ENSG00000115297 |
| Ensembl biotype | protein_coding |
| OMIM | 604240 |
| Entrez | 3196 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000233638, ENST00000464417, ENST00000497238, ENST00000621092
RefSeq mRNA: 1 — MANE Select: NM_016170
NM_016170
CCDS: CCDS1947
Canonical transcript exons
ENST00000233638 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000762883 | 74514450 | 74515206 |
| ENSE00000762885 | 74515633 | 74515870 |
| ENSE00000963409 | 74515973 | 74517148 |
Expression profiles
Bgee: expression breadth broad, 84 present calls, max score 72.59.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6370 / max 306.9011, expressed in 121 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21044 | 0.4905 | 98 |
| 21045 | 0.1140 | 26 |
| 21043 | 0.0325 | 8 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.59 | gold quality |
| transverse colon | UBERON:0001157 | 61.98 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 61.82 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 60.78 | gold quality |
| small intestine | UBERON:0002108 | 60.47 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 60.12 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 59.22 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 58.88 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 58.13 | gold quality |
| intestine | UBERON:0000160 | 57.77 | gold quality |
| colon | UBERON:0001155 | 57.60 | gold quality |
| inferior olivary complex | UBERON:0002127 | 57.52 | gold quality |
| parotid gland | UBERON:0001831 | 57.32 | gold quality |
| large intestine | UBERON:0000059 | 57.01 | gold quality |
| right testis | UBERON:0004534 | 56.62 | gold quality |
| sigmoid colon | UBERON:0001159 | 55.74 | gold quality |
| cerebellar vermis | UBERON:0004720 | 55.36 | gold quality |
| endothelial cell | CL:0000115 | 54.60 | gold quality |
| myocardium | UBERON:0002349 | 54.44 | gold quality |
| left testis | UBERON:0004533 | 54.43 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 54.25 | gold quality |
| heart right ventricle | UBERON:0002080 | 53.75 | gold quality |
| primary visual cortex | UBERON:0002436 | 53.68 | gold quality |
| testis | UBERON:0000473 | 53.09 | gold quality |
| rectum | UBERON:0001052 | 52.52 | gold quality |
| duodenum | UBERON:0002114 | 52.51 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 52.12 | gold quality |
| buccal mucosa cell | CL:0002336 | 51.60 | gold quality |
| decidua | UBERON:0002450 | 51.18 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
6 targets.
| Target | Regulation |
|---|---|
| ANXA5 | |
| NOTCH1 | |
| PHOX2A | |
| PHOX2B | |
| RET | Activation |
| SLC8A3 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1577.1 | TLX2 | NK |
| MA1577.2 | TLX2 | NK |
JASPAR matrix evidence (PMIDs): PMID:10869550
Upstream regulators (CollecTRI, top): PHOX2A, PHOX2B
miRNA regulators (miRDB)
25 targeting TLX2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-19A-5P | 99.36 | 66.93 | 1675 |
| HSA-MIR-19B-1-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-19B-2-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-1228-3P | 99.00 | 66.53 | 857 |
| HSA-MIR-4774-3P | 98.90 | 67.82 | 737 |
| HSA-MIR-500A-5P | 98.76 | 69.13 | 1241 |
| HSA-MIR-6782-3P | 97.60 | 67.75 | 931 |
| HSA-MIR-2467-5P | 97.36 | 67.71 | 991 |
| HSA-MIR-3152-5P | 96.98 | 66.88 | 819 |
| HSA-MIR-3059-3P | 96.71 | 67.08 | 606 |
| HSA-MIR-6834-5P | 96.25 | 64.88 | 823 |
| HSA-MIR-7108-3P | 94.37 | 64.79 | 183 |
Literature-anchored findings (GeneRIF, showing 7)
- This paper describes sequencing and comparison of 5’ flanking regions of the gene, and expression in several neuroblastoma cell lines, in both mouse and human. (PMID:10446220)
- Alignment of sequences obtained from rat, human, and mouse indicates that putative regulatory elements of the Hox11L1 gene are conserved in rat, mice, and humans. (PMID:16291166)
- These results support the PHOX2B-TLX2 promoter interaction, suggesting a physiological role in the transcription-factor cascade underlying the differentiation of neuronal lineages of the Autonomic Nervous System during human embryogenesis. (PMID:16402914)
- Hox11L1 has a role in tumorigenesis in gastrointestinal stromal tumors (PMID:16969514)
- NCX is functionally expressed in developing ventricular human embryonic stem cell-derived ventricular cardiomyocytes and contributes to their excitation-contraction coupling. (PMID:19719399)
- TLX2 is an orphan homeodomain transcription factor whose expression is mainly associated with tissues derived from neural crest cells. (PMID:20044949)
- NCX-TRPC channel interaction constitutes an important functional unit in receptor-mediated divalent calcium ion influx in neuronal cells. (PMID:20728215)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tlx2 | ENSMUSG00000068327 |
| rattus_norvegicus | Tlx2 | ENSRNOG00000055188 |
Paralogs (42): HOXA11 (ENSG00000005073), HOXC8 (ENSG00000037965), HOXA1 (ENSG00000105991), HOXA2 (ENSG00000105996), HOXA3 (ENSG00000105997), HOXA5 (ENSG00000106004), HOXA6 (ENSG00000106006), HOXA13 (ENSG00000106031), TLX1 (ENSG00000107807), HOXB6 (ENSG00000108511), HOXB8 (ENSG00000120068), HOXB5 (ENSG00000120075), HOXB3 (ENSG00000120093), HOXB1 (ENSG00000120094), HOXA7 (ENSG00000122592), HOXC13 (ENSG00000123364), HOXC11 (ENSG00000123388), HOXC12 (ENSG00000123407), HOXD1 (ENSG00000128645), HOXD3 (ENSG00000128652), HOXD9 (ENSG00000128709), HOXD10 (ENSG00000128710), HOXD11 (ENSG00000128713), HOXD13 (ENSG00000128714), PDX1 (ENSG00000139515), HOXB13 (ENSG00000159184), TLX3 (ENSG00000164438), HOXD4 (ENSG00000170166), HOXD12 (ENSG00000170178), HOXB9 (ENSG00000170689), HOXC5 (ENSG00000172789), HOXB2 (ENSG00000173917), HOXD8 (ENSG00000175879), GSX2 (ENSG00000180613), HOXC9 (ENSG00000180806), HOXC10 (ENSG00000180818), HOXB4 (ENSG00000182742), HOXA4 (ENSG00000197576), HOXC6 (ENSG00000197757), HOXC4 (ENSG00000198353)
Protein
Protein identifiers
T-cell leukemia homeobox protein 2 — O43763 (reviewed: O43763)
Alternative names: Homeobox protein Hox-11L1, Neural crest homeobox protein
All UniProt accessions (2): O43763, F1T0F2
UniProt curated annotations — full annotation on UniProt →
Function. Transcription activator that binds DNA elements with the consensus sequence 5’-CGGTAATTGG-3’. Binds DNA via its homeobox. Required for normal cell death of enteric neurons in the gastrointestinal tract. Required for normal development of the enteric nervous system, and for proper development of normal motility of the gastrointestinal tract.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_057254* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR020479 | HD_metazoa | Domain |
| IPR042247 | TLX1/2/3 | Family |
Pfam: PF00046
UniProt features (19 total): sequence conflict 9, helix 3, region of interest 3, compositionally biased region 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3A03 | X-RAY DIFFRACTION | 1.54 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43763-F1 | 68.95 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 132 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_DENDRITE_DEVELOPMENT, GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, BENPORATH_ES_WITH_H3K27ME3, GOBP_FORMATION_OF_PRIMARY_GERM_LAYER, AREB6_03, GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS, GOBP_NEUROGENESIS, GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS, TGACCTY_ERR1_Q2, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GGGTGGRR_PAX4_03, GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION, IRF7_01
GO Biological Process (7): mesoderm formation (GO:0001707), regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of transcription by RNA polymerase II (GO:0045944), enteric nervous system development (GO:0048484), animal organ development (GO:0048513), negative regulation of dendrite morphogenesis (GO:0050774), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), sequence-specific DNA binding (GO:0043565), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| formation of primary germ layer | 1 |
| mesoderm morphogenesis | 1 |
| positive regulation of DNA-templated transcription | 1 |
| autonomic nervous system development | 1 |
| system development | 1 |
| anatomical structure development | 1 |
| negative regulation of cell projection organization | 1 |
| dendrite morphogenesis | 1 |
| regulation of dendrite morphogenesis | 1 |
| negative regulation of neurogenesis | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| DNA binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
624 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TLX2 | IVNS1ABP | Q9Y6Y0 | 825 |
| TLX2 | RANBP17 | Q9H2T7 | 759 |
| TLX2 | SLC8A1 | P32418 | 708 |
| TLX2 | PLN | P26678 | 702 |
| TLX2 | BCL11B | Q9C0K0 | 658 |
| TLX2 | LYL1 | P12980 | 619 |
| TLX2 | RNF223 | E7ERA6 | 609 |
| TLX2 | TAL1 | P17542 | 546 |
| TLX2 | LMO1 | P25800 | 535 |
| TLX2 | TIFAB | Q6ZNK6 | 512 |
| TLX2 | PRODH | O43272 | 497 |
| TLX2 | EDNRB | P24530 | 489 |
| TLX2 | ATP2A2 | P16614 | 477 |
| TLX2 | NKX6-3 | A6NJ46 | 471 |
| TLX2 | TRAM2 | Q15035 | 469 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TLX2 | POU6F2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLX2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLX2 | TLE1 | psi-mi:“MI:0915”(physical association) | 0.520 |
| NFIA | TLX2 | psi-mi:“MI:0915”(physical association) | 0.470 |
| NFIB | TLX2 | psi-mi:“MI:0915”(physical association) | 0.470 |
| NFIC | TLX2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TLX2 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| TLX2 | IRF9 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | GTF2A1L | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | IRF6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | MCM4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | MEIS1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | POU2F1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | ZNF502 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TLX2 | psi-mi:“MI:0914”(association) | 0.350 | |
| TLX2 | IGF2BP3 | psi-mi:“MI:2364”(proximity) | 0.270 |
| TLX2 | POU6F2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TLX2 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (147): TLX2 (Two-hybrid), KRTAP6-2 (Two-hybrid), YWHAH (Reconstituted Complex), TLX2 (Affinity Capture-Western), CUX1 (Proximity Label-MS), TLE1 (Proximity Label-MS), ZFHX3 (Proximity Label-MS), IGF2BP3 (Proximity Label-MS), BCL9 (Proximity Label-MS), NFIB (Proximity Label-MS), ARID1A (Proximity Label-MS), KMT2D (Proximity Label-MS), ZNF609 (Proximity Label-MS), TBL1X (Proximity Label-MS), NCOR1 (Proximity Label-MS)
ESM2 similar proteins: A1YEV8, A1YF08, A1YG25, A1YG85, A2RU54, A2T711, A2T756, A8MTQ0, O14813, O15522, O35160, O35602, O43763, O70218, P28360, P42580, P43687, P50223, P52945, P52946, P52947, P70118, P70354, P81062, Q06348, Q2VL79, Q2VL84, Q2VL85, Q2VL87, Q2VL88, Q61663, Q62066, Q62782, Q6XYB7, Q7YRX0, Q96IS3, Q99811, Q9DED6, Q9ER42, Q9GK08
Diamond homologs: A1YF16, A1YG93, A2RU54, A2T764, A6NCS4, A6NHT5, A8XJD0, F1R2J1, O02786, O35762, O35767, O43711, O43763, O55144, O57601, O70218, O88181, O93366, O93367, O93590, P13297, P19601, P22809, P23410, P26797, P28360, P28361, P28362, P31314, P35548, P35993, P42581, P42582, P42583, P43345, P43687, P50223, P52952, P52953, P56407
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
346 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:74515843:G:GA | donor_gain | 1.0000 |
| 2:74515871:G:GG | donor_gain | 1.0000 |
| 2:74515969:TTAG:T | acceptor_loss | 1.0000 |
| 2:74515970:TAG:T | acceptor_loss | 1.0000 |
| 2:74515971:A:AG | acceptor_gain | 1.0000 |
| 2:74515971:A:AT | acceptor_loss | 1.0000 |
| 2:74515972:G:A | acceptor_loss | 1.0000 |
| 2:74515972:G:GA | acceptor_gain | 1.0000 |
| 2:74515972:GGC:G | acceptor_gain | 1.0000 |
| 2:74515627:C:A | acceptor_gain | 0.9900 |
| 2:74515867:GGCG:G | donor_gain | 0.9900 |
| 2:74515868:GCG:G | donor_gain | 0.9900 |
| 2:74515868:GCGG:G | donor_gain | 0.9900 |
| 2:74515971:AG:A | acceptor_gain | 0.9900 |
| 2:74515971:AGGC:A | acceptor_gain | 0.9900 |
| 2:74515972:GG:G | acceptor_gain | 0.9900 |
| 2:74515972:GGCG:G | acceptor_gain | 0.9900 |
| 2:74515972:GGCGC:G | acceptor_gain | 0.9900 |
| 2:74514651:G:T | donor_gain | 0.9800 |
| 2:74514901:G:GT | donor_gain | 0.9800 |
| 2:74514913:GCC:G | donor_gain | 0.9800 |
| 2:74515631:A:AG | acceptor_gain | 0.9800 |
| 2:74515632:G:GG | acceptor_gain | 0.9800 |
| 2:74515632:GCT:G | acceptor_gain | 0.9800 |
| 2:74515632:GCTGC:G | acceptor_gain | 0.9800 |
| 2:74515204:CGGGT:C | donor_loss | 0.9700 |
| 2:74515205:GG:G | donor_gain | 0.9700 |
| 2:74515205:GGG:G | donor_loss | 0.9700 |
| 2:74515206:GG:G | donor_gain | 0.9700 |
| 2:74515208:T:G | donor_loss | 0.9700 |
AlphaMissense
1777 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:74515722:T:A | F164I | 1.000 |
| 2:74515722:T:C | F164L | 1.000 |
| 2:74515722:T:G | F164V | 1.000 |
| 2:74515723:T:C | F164S | 1.000 |
| 2:74515723:T:G | F164C | 1.000 |
| 2:74515724:C:A | F164L | 1.000 |
| 2:74515724:C:G | F164L | 1.000 |
| 2:74515747:T:C | L172S | 1.000 |
| 2:74515747:T:G | L172W | 1.000 |
| 2:74515748:G:C | L172F | 1.000 |
| 2:74515748:G:T | L172F | 1.000 |
| 2:74515750:A:T | E173V | 1.000 |
| 2:74515758:T:A | F176I | 1.000 |
| 2:74515758:T:C | F176L | 1.000 |
| 2:74515758:T:G | F176V | 1.000 |
| 2:74515759:T:C | F176S | 1.000 |
| 2:74515759:T:G | F176C | 1.000 |
| 2:74515760:C:A | F176L | 1.000 |
| 2:74515760:C:G | F176L | 1.000 |
| 2:74515773:T:C | Y181H | 1.000 |
| 2:74515774:A:G | Y181C | 1.000 |
| 2:74515792:G:T | R187M | 1.000 |
| 2:74515793:G:C | R187S | 1.000 |
| 2:74515793:G:T | R187S | 1.000 |
| 2:74515801:T:C | L190P | 1.000 |
| 2:74515804:C:A | A191D | 1.000 |
| 2:74515819:T:C | M196T | 1.000 |
| 2:74515822:C:T | T197I | 1.000 |
| 2:74515832:G:C | Q200H | 1.000 |
| 2:74515832:G:T | Q200H | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1001269723 (2:74516524 C>A,G,T), RS1002299434 (2:74516533 C>A,T), RS1002650546 (2:74513174 G>A), RS1003302491 (2:74514315 T>C,G), RS1004568469 (2:74513134 A>G), RS1005000278 (2:74512927 C>T), RS1005981549 (2:74514373 C>A,T), RS1007609293 (2:74517328 G>A,C), RS1008139171 (2:74516890 A>G), RS1008817643 (2:74516857 A>C,G), RS1008970645 (2:74516592 G>A,C), RS1009563326 (2:74517302 T>A,C), RS1009594452 (2:74516730 A>G), RS1011426997 (2:74513462 G>A), RS1011872109 (2:74513225 G>A,C)
Disease associations
OMIM: gene MIM:604240 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| Valproic Acid | increases expression, affects expression | 2 |
| aristolochic acid I | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | increases expression | 1 |
| terbufos | increases methylation | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| beta-lapachone | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Ozone | increases oxidation, increases expression | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Asbestos, Serpentine | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Asbestos, Amosite | decreases methylation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.